Insider Trading activities of Cymabay Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cymabay Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cymabay Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Cymabay Therapeutics, Inc. since 2005. The reporting company's ticker symbol is CBAY. The reporting company's CIK number is 1042074.
The total value of stock buying since 2005 is $6,269,576.
The total value of stock sales since 2005 is $16,861,405.
The total value of stock option exercises since 2005 is $120,960.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Cymabay Therapeutics, Inc. (CBAY).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-06 0 $0 920 $11,509 0 $0
2018-05 5,000 $53,250 0 $0 0 $0
2018-03 0 $0 28,353 $402,480 15,000 $78,750
2018-02 0 $0 436,461 $6,286,499 0 $0
2018-01 0 $0 423,846 $4,633,027 0 $0
2017-12 0 $0 173,192 $1,629,390 0 $0
2017-11 5,000 $43,345 72,368 $659,255 18,000 $42,210
2017-10 0 $0 168,085 $1,403,673 0 $0
2017-09 0 $0 211,124 $1,707,379 0 $0
2017-08 5,000 $34,190 0 $0 0 $0
2017-07 168,846 $1,110,269 0 $0 0 $0
2016-09 25,000 $60,850 0 $0 0 $0
2016-04 63,000 $89,689 0 $0 0 $0
2015-09 0 $0 46,729 $128,193 0 $0
2015-08 90,000 $242,497 0 $0 0 $0
2015-07 1,600,000 $4,496,000 0 $0 0 $0
2015-05 19,500 $65,086 0 $0 0 $0
2014-09 10,000 $74,400 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Cymabay Therapeutics, Inc. insiders (CBAY)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-06-05 Emster Kurt Von Sale 920 12.51 11,509
2018-05-11 Shah Sujal (Chief Executive Officer) Buy 5,000 10.65 53,250
2018-03-22 Goldfischer Carl (Director) Sale 15,000 13.03 195,375
2018-03-22 Goldfischer Carl (Director) Option Ex 15,000 5.25 78,750
2018-03-05 Emster Kurt Von Sale 13,353 15.51 207,105
2018-02-15 Emster Kurt Von Sale 68,712 14.49 995,636
2018-02-14 Emster Kurt Von Sale 162,979 16.69 2,720,119
2018-02-13 Emster Kurt Von Sale 55,078 13.51 744,103
2018-02-07 Emster Kurt Von Sale 40,763 12.35 503,423
2018-02-05 Emster Kurt Von Sale 18,831 12.14 228,608
2018-02-02 Emster Kurt Von Sale 2,000 12.11 24,220
2018-02-01 Emster Kurt Von Sale 88,098 12.15 1,070,390
2018-01-31 Emster Kurt Von Sale 12,300 12.23 150,429
2018-01-30 Emster Kurt Von Sale 85,339 12.22 1,042,842
2018-01-25 Emster Kurt Von Sale 39,438 12.18 480,354
2018-01-22 Emster Kurt Von Sale 138,253 10.40 1,437,831
2018-01-19 Emster Kurt Von Sale 130,584 10.25 1,338,486
2018-01-18 Emster Kurt Von Sale 13,632 10.21 139,182
2018-01-05 Emster Kurt Von Sale 4,300 10.21 43,903
2017-12-22 Emster Kurt Von Sale 173,192 9.41 1,629,390
2017-11-10 Emster Kurt Von Sale 50,048 9.26 463,394
2017-11-02 Mcwherter Charles (SVP & Chief Scientific Officer) Buy 5,000 8.67 43,345
2017-11-02 Goldfischer Carl (Director) Sale 18,000 8.66 155,880
2017-11-02 Goldfischer Carl (Director) Option Ex 18,000 2.35 42,210
2017-11-01 Emster Kurt Von Sale 4,320 9.26 39,981
2017-10-31 Emster Kurt Von Sale 52,573 9.27 487,351
2017-10-30 Emster Kurt Von Sale 6,636 9.26 61,449
2017-10-03 Emster Kurt Von Sale 70,940 7.81 554,041
2017-10-02 Emster Kurt Von Sale 37,936 7.93 300,832
2017-09-29 Emster Kurt Von Sale 120,735 8.04 970,709
2017-09-28 Emster Kurt Von Sale 90,389 8.15 736,670
2017-08-01 Wills Robert James (Director) Buy 5,000 6.84 34,190
2017-07-20 Mcwherter Charles (SVP & Chief Scientific Officer) Buy 5,000 7.43 37,130
2017-07-20 Shah Sujal (Interim President & CEO) Buy 10,000 7.31 73,140
2017-07-19 Emster Kurt Von Buy 153,846 6.50 999,999
2016-09-06 Wills Robert James Buy 25,000 2.43 60,850
2016-04-15 Omara Patrick J. (VP, Business Development) Buy 5,000 1.64 8,200
2016-04-15 Mcwherter Charles (Sr. Vice President) Buy 3,000 1.68 5,040
2016-04-05 Shah Sujal (Chief Financial Officer) Buy 33,000 1.39 45,870
2016-04-04 Shah Sujal (Chief Financial Officer) Buy 22,000 1.39 30,579
2015-09-11 Goldfischer Carl Sale 15,467 2.76 42,735
2015-09-10 Goldfischer Carl Sale 16,500 2.71 44,715
2015-09-09 Goldfischer Carl Sale 14,762 2.76 40,743
2015-08-14 Von Emster Kurt Buy 58,641 2.70 158,330
2015-08-13 Von Emster Kurt Buy 31,359 2.68 84,167
2015-07-20 Von Emster Kurt Buy 1,600,000 2.81 4,496,000
2015-05-18 Shah Sujal (Chief Financial Officer) Buy 10,000 3.40 34,000
2015-05-18 Van Wart Harold (President and CEO) Buy 7,500 3.30 24,772
2015-05-15 Mcwherter Charles (Sr. Vice President) Buy 2,000 3.16 6,314
2014-09-16 Shah Sujal (Chief Financial Officer) Buy 10,000 7.44 74,400

Insider trading activities including stock purchases, stock sales, and option exercises of CBAY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cymabay Therapeutics, Inc. (symbol CBAY, CIK number 1042074) see the Securities and Exchange Commission (SEC) website.